Mass Spec at the Analytical–Clinical Interface
The fight against disease is in no way an easy one – could the power of mass spectra prove to be mankind’s secret weapon?
Matthew Hallam, Candice Z. Ulmer, John Yates, Donald Chace, Peter Nemes | | Longer Read
The role of MS in screening, monitoring, and subsequently improving patient health has far-reaching implications – from giving premature babies a fighting chance to evaluating environmental factors that contribute to disease. These applications span the clinical research spectrum, from the operating room to the lab bench, and – thanks to instrumental advances and the increasing power of data processing methods – are becoming increasingly important. Here, four influential analytical scientists – Candice Ulmer, John Yates, Donald Chace, and Peter Nemes – detail how they are wielding the power of mass spectra to identify, support and treat patients now and in the future.
Omics and Public Health
By Candice Z. Ulmer, Research Chemist & Associate Service Fellow, Clinical Chemistry Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
As a Clinical Research Chemist at the Centers for Disease Control and Prevention, my responsibilities include the planning and execution of programs for the harmonization and accurate reporting of chronic disease biomarkers – and other biomarkers deemed important by stakeholder organizations, including parathyroid hormone (PTH), anti-müllerian hormone, follicle stimulating hormone, luteinizing hormone, and steroid hormones.
We study these markers to enhance the diagnosis and treatment of select endocrine diseases and advance CDC Standardization Programs – aimed at improving the accuracy and precision of these same measurements, and many more, in patient care. In fact, I now ensure the accurate reporting of 17 such analytes, including the examples mentioned above, in addition to further roles generating population data, training laboratory professionals, and acting on the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Bone Metabolism and the Clinical Chemistry Committee for the American Society for Mass Spectrometry.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.